The Role of Endoscopic Ultrasound in Pancreatic Cancer Staging in the Era of Neoadjuvant Therapy and Personalised Medicine
Abstract: Precise staging of pancreatic cancer is crucial for treatment choice. In clinical practice, this includes the TNM staging and determination of tumour resectability, based on a multimodality imaging workup. International guidelines recommend multi-detector computed tomography (CT), with a dedicated pancreatic protocol, as the first-line tool for TNM staging and evaluation of tumour-vessel relationships. In non-metastatic disease upon initial CT assessment, both magnetic resonance imaging and endoscopic ultrasound (EUS) may add relevant information, potentially changing treatment sequence. EUS may have distinct advantages in pancreatic cancer diagnosis and staging when compared with other modalities, being particularly valuable in the determination of portal venous confluence involvement (particularly in small and ill defined/isoattenuating tumours on CT), in locoregional nodal staging and in the detection of ascites. As we step forward to a more frequent use of neoadjuvant chemotherapy and to personalised medicine, the importance of EUS-guided fine-needle biopsy (EUS-FNB) also increases. The recent availability of third-generation biopsy needles significantly increased the diagnostic yield of EUS-guided tissue acquisition, providing diagnostic cell blocks in approximately 95% of cases with only two dedicated passes and allowing ancillary testing, such as immunohistochemistry and molecular profiling of the tumour. In this article, the authors present an updated perspective of the place of EUS and EUS-FNB in the staging algorithm of pancreatic cancer. Data supporting the increasing role of neoadjuvant therapy and the importance of a patient tailored treatment selection, based on tumoural subtyping and molecular profiling, are also discussed.
Main Authors: | , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Portuguesa de Gastrenterologia
2021
|
Online Access: | http://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452021000200111 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S2341-45452021000200111 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S2341-454520210002001112022-01-13The Role of Endoscopic Ultrasound in Pancreatic Cancer Staging in the Era of Neoadjuvant Therapy and Personalised MedicineBispo,MiguelMarques,SusanaRio-Tinto,RicardoFidalgo,PauloDevière,Jacques Endoscopic ultrasound Fine-needle biopsy Neoadjuvant therapy Pancreatic cancer staging Personalised medicine Precision therapy Abstract: Precise staging of pancreatic cancer is crucial for treatment choice. In clinical practice, this includes the TNM staging and determination of tumour resectability, based on a multimodality imaging workup. International guidelines recommend multi-detector computed tomography (CT), with a dedicated pancreatic protocol, as the first-line tool for TNM staging and evaluation of tumour-vessel relationships. In non-metastatic disease upon initial CT assessment, both magnetic resonance imaging and endoscopic ultrasound (EUS) may add relevant information, potentially changing treatment sequence. EUS may have distinct advantages in pancreatic cancer diagnosis and staging when compared with other modalities, being particularly valuable in the determination of portal venous confluence involvement (particularly in small and ill defined/isoattenuating tumours on CT), in locoregional nodal staging and in the detection of ascites. As we step forward to a more frequent use of neoadjuvant chemotherapy and to personalised medicine, the importance of EUS-guided fine-needle biopsy (EUS-FNB) also increases. The recent availability of third-generation biopsy needles significantly increased the diagnostic yield of EUS-guided tissue acquisition, providing diagnostic cell blocks in approximately 95% of cases with only two dedicated passes and allowing ancillary testing, such as immunohistochemistry and molecular profiling of the tumour. In this article, the authors present an updated perspective of the place of EUS and EUS-FNB in the staging algorithm of pancreatic cancer. Data supporting the increasing role of neoadjuvant therapy and the importance of a patient tailored treatment selection, based on tumoural subtyping and molecular profiling, are also discussed.info:eu-repo/semantics/openAccessSociedade Portuguesa de GastrenterologiaGE-Portuguese Journal of Gastroenterology v.28 n.2 20212021-04-01info:eu-repo/semantics/articletext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452021000200111en10.1159/000509197 |
institution |
SCIELO |
collection |
OJS |
country |
Portugal |
countrycode |
PT |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-pt |
tag |
revista |
region |
Europa del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Bispo,Miguel Marques,Susana Rio-Tinto,Ricardo Fidalgo,Paulo Devière,Jacques |
spellingShingle |
Bispo,Miguel Marques,Susana Rio-Tinto,Ricardo Fidalgo,Paulo Devière,Jacques The Role of Endoscopic Ultrasound in Pancreatic Cancer Staging in the Era of Neoadjuvant Therapy and Personalised Medicine |
author_facet |
Bispo,Miguel Marques,Susana Rio-Tinto,Ricardo Fidalgo,Paulo Devière,Jacques |
author_sort |
Bispo,Miguel |
title |
The Role of Endoscopic Ultrasound in Pancreatic Cancer Staging in the Era of Neoadjuvant Therapy and Personalised Medicine |
title_short |
The Role of Endoscopic Ultrasound in Pancreatic Cancer Staging in the Era of Neoadjuvant Therapy and Personalised Medicine |
title_full |
The Role of Endoscopic Ultrasound in Pancreatic Cancer Staging in the Era of Neoadjuvant Therapy and Personalised Medicine |
title_fullStr |
The Role of Endoscopic Ultrasound in Pancreatic Cancer Staging in the Era of Neoadjuvant Therapy and Personalised Medicine |
title_full_unstemmed |
The Role of Endoscopic Ultrasound in Pancreatic Cancer Staging in the Era of Neoadjuvant Therapy and Personalised Medicine |
title_sort |
role of endoscopic ultrasound in pancreatic cancer staging in the era of neoadjuvant therapy and personalised medicine |
description |
Abstract: Precise staging of pancreatic cancer is crucial for treatment choice. In clinical practice, this includes the TNM staging and determination of tumour resectability, based on a multimodality imaging workup. International guidelines recommend multi-detector computed tomography (CT), with a dedicated pancreatic protocol, as the first-line tool for TNM staging and evaluation of tumour-vessel relationships. In non-metastatic disease upon initial CT assessment, both magnetic resonance imaging and endoscopic ultrasound (EUS) may add relevant information, potentially changing treatment sequence. EUS may have distinct advantages in pancreatic cancer diagnosis and staging when compared with other modalities, being particularly valuable in the determination of portal venous confluence involvement (particularly in small and ill defined/isoattenuating tumours on CT), in locoregional nodal staging and in the detection of ascites. As we step forward to a more frequent use of neoadjuvant chemotherapy and to personalised medicine, the importance of EUS-guided fine-needle biopsy (EUS-FNB) also increases. The recent availability of third-generation biopsy needles significantly increased the diagnostic yield of EUS-guided tissue acquisition, providing diagnostic cell blocks in approximately 95% of cases with only two dedicated passes and allowing ancillary testing, such as immunohistochemistry and molecular profiling of the tumour. In this article, the authors present an updated perspective of the place of EUS and EUS-FNB in the staging algorithm of pancreatic cancer. Data supporting the increasing role of neoadjuvant therapy and the importance of a patient tailored treatment selection, based on tumoural subtyping and molecular profiling, are also discussed. |
publisher |
Sociedade Portuguesa de Gastrenterologia |
publishDate |
2021 |
url |
http://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452021000200111 |
work_keys_str_mv |
AT bispomiguel theroleofendoscopicultrasoundinpancreaticcancerstagingintheeraofneoadjuvanttherapyandpersonalisedmedicine AT marquessusana theroleofendoscopicultrasoundinpancreaticcancerstagingintheeraofneoadjuvanttherapyandpersonalisedmedicine AT riotintoricardo theroleofendoscopicultrasoundinpancreaticcancerstagingintheeraofneoadjuvanttherapyandpersonalisedmedicine AT fidalgopaulo theroleofendoscopicultrasoundinpancreaticcancerstagingintheeraofneoadjuvanttherapyandpersonalisedmedicine AT devierejacques theroleofendoscopicultrasoundinpancreaticcancerstagingintheeraofneoadjuvanttherapyandpersonalisedmedicine AT bispomiguel roleofendoscopicultrasoundinpancreaticcancerstagingintheeraofneoadjuvanttherapyandpersonalisedmedicine AT marquessusana roleofendoscopicultrasoundinpancreaticcancerstagingintheeraofneoadjuvanttherapyandpersonalisedmedicine AT riotintoricardo roleofendoscopicultrasoundinpancreaticcancerstagingintheeraofneoadjuvanttherapyandpersonalisedmedicine AT fidalgopaulo roleofendoscopicultrasoundinpancreaticcancerstagingintheeraofneoadjuvanttherapyandpersonalisedmedicine AT devierejacques roleofendoscopicultrasoundinpancreaticcancerstagingintheeraofneoadjuvanttherapyandpersonalisedmedicine |
_version_ |
1756004342017556480 |